Skip to content
Contention over the Bayh-Dole march-in rights provision is in the news again. The National Institute of Standards and Technology (NIST) proposes using the process […]
BIO comments on NIST proposal to use march-in rights for price controls Read More »
Breakthroughs in biotech involve collaboration at every level. While entrepreneurial innovation is often the most visible, it’s policymaking and government leadership that lays the
Black History Month: the policymakers & government leaders advancing biotech Read More »
A proposed World Trade Organization (WTO) IP waiver could have scuttled investment in biotech’s new diabetes drug and already impacts the firm’s decisions about
BIO Board member tells Congress WTO IP waivers hurt innovation Read More »
Tuesday, Feb. 6 was a busy day on Capitol Hill for health legislation. Two bills advanced through committees. The House Oversight & Investigations Committee
Legislation on PBM reform, preventive care advances in House Read More »
The world’s first ethanol-to-sustainable aviation fuel (SAF) plant opened in the U.S. takes the world one step closer to a greener future. On Jan.
LanzaJet opens world’s first ethanol-to-SAF production plant Read More »
The U.S. Trade Representative (USTR) needs to call out worldwide intellectual property deficiencies that harm U.S. biotech innovation—and they must not support a proposed
BIO report to USTR on global IP threats warns against TRIPS waiver Read More »
February marks Black History Month, an important annual reminder of the contributions Black and African Americans have made to the progress of biotechnology, and
Black History Month pioneers: advancing science and representation Read More »
A bipartisan amendment to the Inflation Reduction Act (IRA), introduced in the House on January 31, would fix the law’s small molecule “pill penalty”
EPIC Act would fix IRA’s ‘pill penalty’ for small molecule drugs Read More »
On January 31, the House passed legislation to restore the immediate expensing of R&D expenses. The Biotechnology Innovation Organization (BIO) has long advocated for
House passes bill restoring full R&D expensing Read More »
“If you want to go fast, go alone,” said Interim Dean of UCLA’s Division of Social Sciences, Abel Valenzuela Jr., giving opening remarks at
When Medicine Stops Saving Us: The Antimicrobial Resistance Crisis Read More »
